Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Antibe Therapeutics Inc(Pre-Merger)
ATBPF
Healthcare
Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,...
otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:ATBPF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Nov 23, 2023 8:35pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:comgrats
Not sure why you think chronic has to go through preclinical but you stay on that path. That's a conservative way to look at it. I'm more interested in the pipeline and I have been for
...more
(62)
•••
WalkOverTheStrt
X
View Profile
View Bullboard History
Comment by
WalkOverTheStrt
on Nov 23, 2023 11:29am
RE:RE:RE:RE:RE:RE:RE:RE:RE:comgrats
Mugsy - your point I was in disagreed with was outside Otena pipeline. As in their other pipeline (currently preclinicial) that have for over five years gone no where but the company has spent
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Nov 22, 2023 11:19pm
RE:RE:RE:RE:RE:RE:RE:RE:comgrats
I've been clear that I don't follow general percentages of success when it comes to OTENA - nor did I ever give up on chronic. If you think there is only one path or that daily chronic
...more
(62)
•••
WalkOverTheStrt
X
View Profile
View Bullboard History
Comment by
WalkOverTheStrt
on Nov 22, 2023 9:31am
RE:RE:RE:RE:RE:RE:RE:comgrats
Mugsy - Hard disagree with your below statement. Every dollar Atibe spend on other drugs puts greater risk to Otenal until that one is over the finish line. Valuations on pipeline for animal studies
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Nov 19, 2023 8:55am
RE:RE:RE:RE:RE:RE:comgrats
OTENA is likely as good as it will get. Now the clinical team to push it through. Every additional direction will help generate value going forward - but you need to do the exploratory work and
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Nov 19, 2023 8:36am
RE:RE:RE:RE:RE:RE:comgrats
Yes - still around but I can't say how active.
(62)
•••
WalkOverTheStrt
X
View Profile
View Bullboard History
Comment by
WalkOverTheStrt
on Nov 19, 2023 8:25am
RE:RE:RE:RE:RE:comgrats
Bagger, I see what you did on my alias clever.... I think your misinformed as I've held the stock for over five years now and with that a loss on paper over six digits. I don't need your
...more
(7)
•••
Fairplaymtl
X
View Profile
View Bullboard History
Comment by
Fairplaymtl
on Nov 18, 2023 3:52pm
RE:RE:RE:RE:RE:comgrats
I don't care like that. He is probably liquidating. But he is still around?
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Nov 18, 2023 3:05pm
RE:RE:RE:RE:comgrats
I guess I should clarify ... Over time, we all lose with Wallace retiring. Though I have credible information that says he's recently been around - but - that's neither here nor there
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Nov 18, 2023 2:56pm
RE:RE:RE:comgrats
You are probably right - and - that is unfortunate for you, me, ATE and for Wallace. Believe it or not ... we all lose. Every - single - one - of - us.
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Nov 18, 2023 2:53pm
RE:RE:RE:RE:RE:comgrats
I have to agree. Any fear of Dan should lead you to exit this stock and look for something more comfortable for your investment dollar. I think if you look at the make-up of the development team and
...more
(7)
•••
Fairplaymtl
X
View Profile
View Bullboard History
Comment by
Fairplaymtl
on Nov 18, 2023 2:37pm
RE:RE:comgrats
To my knowledge M. Wallace is not an insider
(218)
•••
baggerx99
X
View Profile
View Bullboard History
Comment by
baggerx99
on Nov 18, 2023 1:48pm
RE:RE:RE:RE:comgrats
Street walker; seems your misinformed, my suggestion is for you to start at ground zero of the Antibe story....you may better understand the narrative and timelines associated with all the ups and
...more
(62)
•••
WalkOverTheStrt
X
View Profile
View Bullboard History
Comment by
WalkOverTheStrt
on Nov 18, 2023 1:25pm
RE:RE:RE:comgrats
Mugs I don't have a high view of Dan so I look at his sales of stock as a potential indicator, a data point. If mgmt bought on the open market that would be a nice sign of confidence. I'
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Nov 18, 2023 10:13am
RE:RE:comgrats
I hope you are just kidding WalkOverTheStrt. That question will never lead to understanding the drug, the true value of the drug or where P2 and P3 are going. I know that many use that as a
...more
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >